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 A large outbreak of adenovirus type 4-
associated acute respiratory disease (ARD)
occurred at Fort Jackson, South Carolina, the
U.S. Army’s largest basic training center (1) from
May through December 1997. During the latter
half of 1997, ARD hospitalizations were reported
in basic trainee populations from all army
training centers. However, the highest rates
(≥ 1% of all trainees per week) were at Fort
Jackson and at Fort Leonard Wood, Missouri (2).
After completing an 8-week basic training,
soldiers generally enter the second phase of
military specialty training, advanced individual
training, which is offered at various U.S. Army
posts. Fort Gordon, Georgia, receives soldiers
directly from Fort Jackson (approximately 150
km away) and other basic training centers. From
August to December 1997, the average advanced
training population at Fort Gordon was 3,600
soldiers; 80% came from Fort Jackson, approxi-
mately 10% from Fort Leonard Wood, and 10%
from other sites. Most soldiers proceed directly to
advanced training upon graduation from basic
training at Fort Jackson. Concern that adenovi-
rus-associated ARD might spread to advanced
training students at Fort Gordon led to an
intensive, laboratory-based ARD surveillance
program at this site on April 1, 1997.
The Study
Female and male soldiers in advanced
training live in barracks at Fort Gordon and
receive medical care at the army hospital.
Soldiers report to outpatient clinics during the
day or to the emergency department during
evenings and weekends. Local medical policy
requires hospitalization of advanced training
soldiers with ARD symptoms (one or more signs
or symptoms of acute respiratory infection and
oral temperature of ≥ 38.06°C). Approximately
80% of advanced training soldiers admitted to the
Fort Gordon hospital who met the case definition
were enrolled in the surveillance program.
A questionnaire was used to record basic
training site, date of reporting to Fort Gordon,
and date of onset of symptoms for each trainee. A
pharyngeal swab was taken from each trainee,
placed directly into virus transport medium
(Viromed Laboratories, Inc., Minneapolis, MN),
and immediately transported to the laboratory at
the Dwight David Eisenhower Army Medical
Center, Fort Gordon. All procedures performed
on human subjects met ethical standards
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A large outbreak of adenovirus type 4-associated acute respiratory disease (ARD)
occurred at Fort Jackson, South Carolina, in 1997. A laboratory-based ARD surveillance
program was initiated at Fort Gordon, Georgia, where advanced individual training was
heavily populated with Fort Jackson soldiers. Adenovirus type 4 was isolated from 50%
of 147 trainees hospitalized with ARD. Most (88%) introduced cases were in trainees
from Fort Jackson.Dispatches
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established by the Institutional Review Commit-
tee of the medical center.
Viruses were isolated and identified in the
Virus Isolation Laboratory, Dwight David
Eisenhower Army Medical Center. Adenoviruses
were isolated on human lung carcinoma (A-549)
cells. Serotypes were determined by virus
neutralization (3) with type-specific antisera
(Centers for Disease Control and Prevention,
Atlanta, GA) by the Reed-Muench method for
calculation of the 50% lethal dose titer (4).
Cultures were also examined by standard virus
isolation and identification for influenza A and B;
parainfluenza 1, 2, and 3; herpes simplex; and
enteroviruses. In addition to human lung
carcinoma, primary rhesus monkey kidney and
human foreskin cell lines were used to screen for
viral agents. A pharyngeal swab was obtained
from most study participants for isolation of
Streptococcus pyogenes, Group A, by using
standard methods.
The incubation period for adenovirus ARD is
generally ≤ 10 days (5,6). Patients who had been
at Fort Gordon for ≤ 10 days before the onset of
ARD symptoms were classified as having been
infected elsewhere (introduced cases). Patients
who had been at Fort Gordon for >10 days before
onset were classified as having acquired adenovi-
rus infection at Fort Gordon (secondary cases).
From April 17 to May 14, 1997, a survey was
undertaken to determine if adenoviruses were
circulating in trainees who did not exhibit classic
ARD. Throat swabs for virus isolation were
performed on 180 randomly selected Fort Gordon
advanced training soldiers who reported to clinic
for treatment of minor illnesses, including
afebrile upper respiratory infections.
The first isolate of adenovirus type 4 was
from a specimen collected on August 19, 1997,
from an advanced training soldier whose illness
met the case definition of ARD. None of the
specimens obtained from advanced training
soldiers without ARD yielded adenovirus. From
August 1, 1997, through December 31, 1997, 147
advanced training cases from four basic training
sites that met the ARD case definition were
studied; 73 (49.7%) patients had positive test
results for adenovirus type 4. Each began basic
training after adenovirus vaccination had ceased.
Of the 73, 7 (9.6%) completed basic training at
Fort Leonard Wood; 6 (8.2%) trained at Fort Sill,
Oklahoma; 3 (4.1%) trained at Fort Knox,
Kentucky; and 57 (78.1%) trained at Fort
Jackson. The 57 adenovirus type 4-positive
soldiers included 47 (82.5%) men and 10 (17.5%)
women with a median age of 19 years (range 17 to
33 years). This gender distribution closely
mirrored that of the total advanced training
population at Fort Gordon (approximately 80%
male and 20% female).
Of 119 cases in soldiers who had performed
basic training at Fort Jackson, 57 (47.9%) were
adenovirus type-4 positive; of these cases, 22
(38.6%) were introduced and the remaining 35
(61.4%) were attributed to local transmission at
Fort Gordon (Figure 1). Thirty-three other ARDDispatches
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causative agents were isolated from the 62
persons who were adenovirus type-4 negative.
This resulted in an identifiable cause of ARD in
90 (75.6%) soldiers. Twenty-seven of the other
agents were viruses. These included eight
isolates of herpes simplex; eight of adenovirus
type 21; four of parainfluenza type 3; five of
adenovirus type 2; one of influenza B; and one
mixed infection of adenovirus types 2 and 3. Six
other trainees were positive for Streptococcus
pyogenes, Group A. Two trainees with mixed
infections of S. pyogenes, Group A, and adenovirus
type 2 and adenovirus type 4, respectively, were
identified.
The patient with the initial adenovirus type 4
isolate on August 19, 1997, had arrived from Fort
Jackson on June 20, 1997. Twenty-five (34.2%) of
the 73 cases of adenovirus type 4-associated ARD
were classified as introduced; 48 (65.8%) were
classifed as secondary (Figure 2). Of the introduced
cases, 22 (88.0%) were in trainees from Fort
Jackson. The remaining three were in trainees
from three basic training sites, who arrived at
Fort Gordon on October 15 or later. Twelve of the
trainees from Fort Jackson who had introduced
cases had onset of symptoms 1 day before
arriving at Fort Gordon (day –1) to 4 days after
arrival (day+4). The earliest identified, intro-
duced cases were in trainees who arrived at Fort
Gordon on August 29. One became ill the day of
arrival, and the second, 3 days after arrival.
The outbreak persisted until December 12,
1997, when the last adenovirus type 4 isolate was
identified as a secondarily acquired infection in
an advanced training soldier who had not trained
at Fort Jackson (Figures 1, 2).
Conclusions
Adenovirus type 4 was not isolated in 180
non-ARD patients cultured during April and
May, indicating that the virus was not then
circulating widely, if at all, at Fort Gordon. We
stopped culturing non-ARD patients because of
the increased workload in the medical center’s
virus laboratory caused by the ARD outbreak at
Fort Jackson. Adenovirus type 4 was not isolated
from ARD patients at Fort Gordon until August
19. The index patient had reported to Fort
Gordon 58 days before onset of illness, a period
much longer than the usual incubation period for
adenovirus type 4; we classified that case as
secondary, although it is possible that the patient
was infected at Fort Jackson and excreted
adenovirus type 4 at Fort Gordon without
symptoms of clinical illness until August. Virus
watch programs recognize infections with little or
no illness and brief excretion of virus as well as
persistent infections often characterized by
illness and periods of intermittent virus
excretion that can exceed 100 days (7,8). We were
unable to identify the trainee who introduced
adenovirus type 4 to Fort Gordon from a basic
training center.
Our data are consistent with the introduction
of adenovirus type 4 (with subsequent virus
circulation) to Fort Gordon during June toDispatches
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August, probably by a trainee from Fort Jackson.
The likely spread of adenovirus type 4 from Fort
Jackson to Fort Gordon is supported by the
temporal relationship between the outbreaks at
the two sites and the laboratory-proven
adenovirus type 4 infections in soldiers arriving
at Fort Gordon from Fort Jackson. Immuniza-
tions for adenovirus type 4 ceased at Fort
Jackson and elsewhere in the army on April 1,
1997, and the adenovirus type 4 ARD outbreak in
Fort Jackson basic trainees began in May (1).
Since basic training was 8 weeks, the first cohort
of nonimmunized soldiers arrived at Fort Gordon
at the beginning of June. Strain variations have
been described in isolates of adenovirus type 4
(9). Molecular identification procedures were not
available in military laboratories at the time of
this outbreak, and the cost of molecular
characterization or other tests to compare
isolates from basic training centers and Fort
Gordon were beyond the study budget.
The adenovirus type 4 outbreak in the
advanced training population at Fort Gordon
differed from the much larger outbreak in Fort
Jackson basic trainees. At Fort Jackson,
adenovirus type 4 accounted for more than 90% of
ARD hospitalizations toward the end of the 1997
epidemic (3). At Fort Gordon, isolation of
adenovirus type 4 occurred less often: <50% of
soldiers hospitalized with ARD at Fort Gordon
had an adenovirus isolated. Among the remain-
ing  50%, a potential respiratory pathogen was
identified for 53.2%. Laboratory tests to identify
Mycoplasma pneumoniae and Chlamydia
pneumoniae as causes of ARD were not available
for this study (10).
ARD rates were much lower at Fort Gordon
than at Fort Jackson (Figure 2). At its peak, the
Fort Jackson outbreak produced an attack rate of
26.45 cases per 1,000 soldiers per month. The
highest attack rate at Fort Gordon in advanced
training soldiers was 7.50 cases per 1,000
soldiers per month. Various factors including
naturally acquired immunity from exposure to
outbreaks during basic training, less crowded
housing in advanced training (two-person rooms
in advanced training versus open barracks in
basic training), and less physical stress in the
highly technical Fort Gordon training program
may have limited the magnitude of that outbreak.
The outbreak among advanced training
soldiers at Fort Gordon supports the hypothesis
that the spread of adenovirus type 4 from one
training site to another can occur. This outbreak
also demonstrates that adenovirus type 4-
associated ARD occurs in advanced training
soldiers and results in hospitalizations. Since a
new adenovirus vaccine manufacturer has not
yet been identified, the U.S. military may not
have adenovirus type 4 or 7 vaccines until 2004 or
beyond. Surveillance must be conducted at basic
and advanced training centers with special
consideration given to studying adenovirus
transmission. Understanding the variables
associated with virus spread could lead to
effective nonvaccine interventions.
Acknowledgment
The authors thank Johnnie Conolly of Moncrief Army
Community Hospital, Fort Jackson, South Carolina, for her
invaluable and expert technical assistance.
Dr. McNeill is a district health director with the
South Carolina Department of Health and Environmen-
tal Control. He was formerly Chief, Preventive Medicine
Service, Dwight David Eisenhower Army Medical Cen-
ter, Fort Gordon, Ga. His special interest is the labora-
tory-based surveillance of communicable diseases.
References
  1. McNeill KM, Hendrix RM, Lindner JL, Benton FR,
Monteith SC, Tuchscherer MA, et al. Reemergence of
adenovirus type 4-associated acute respiratory disease
in U.S. army trainees: report of a large, persistent
epidemic. Emerg Infect Dis 1999;5;798-801.
    2. ARD Surveillance Update. Medical Surveillance
Monthly Report, Army Medical Surveillance Activity
1998;4:13.
    3. Lennette DA. General principles for laboratory
diagnosis of viral, rickettsial, and chlamydial
infections. In: Lennette EH, Lennette DA, Lennette
ET, editors. Diagnostic procedures for viral, rickettsial,
and chlamydial infections. 7th ed. Washington:
American Public Health Association; 1995. p. 3-25.
  4. Reed LJ, Muench H. A simple method of estimating
fifty percent endpoints. American Journal of Hygiene
1938;27:493-7.
    5. Foy HM. Adenoviruses. In: Evans AS, Kaslow RA,
editors. Viral infections in humans. 4th ed. New York:
Plenum Press; 1997; p. 119-38.
  6. Gaydos CA, Gaydos JC. Adenovirus vaccines, 1999. In:
Plotkin SA, Orenstein WA, editors. Vaccines. 3rd ed.
Philadelphia: WB Saunders; 1999. p. 609-28.
    7. Fox JP, Brandt CD, Wassermann FE, Hall CE,
Spigland I, Kagan A, et al. The virus watch program: a
continuing surveillance of viral infections in metropolitan
New York families. VI. Observations of adenovirus
infections: virus excretion patterns, antibody response,
efficiency of surveillance, patterns of infection, and
relation to illness. Am J Epidemiol 1969;89:25-50.Dispatches
419 Vol. 6, No. 4, July–August 2000 Emerging Infectious Diseases
  8. Fox JP, Hall CE, Cooney MK. The Seattle virus watch.
VII. Observations of adenovirus infections. Am J
Epidemiol 1977;105:362-86.
  9. Crawford-Mikoza LK, Nang RN, Schnurr DP. Strain
variation in adenovirus serotypes 7 and 7a causing
acute respiratory disease. J Clin Microbiol
1999;37:1107-12.
10. Gray GC, Callahan JD, Hawksworth AW, Fisher CA,
Gaydos JC. Respiratory diseases among U.S. military
personnel: countering emerging threats. Emerg Infect
Dis 1999;5:379-87.